Dallas, Texas, Aug. 10, 2017 -- Dr. Lori Stetler and Dr. Kristel Polder, of Dallas Center for Dermatology and Aesthetics, are among the first doctors in Dallas to perform upper arm fat reduction treatment with CoolSculpting, the first and only FDA-cleared technology to address this area of the body. 2
CoolSculpting works by gently cooling targeted fat cells in the body and producing a natural, controlled elimination of these fat cells without affecting surrounding tissue. While CoolSculpting has been used to treat other areas of the body, the recent FDA clearance of its CoolAdvantage™ Petite Applicator makes it the only non-invasive fat removal technology available in the U.S. to address upper arm fat.
“We’ve had a waiting list for months of patients who are ready to say goodbye to their ‘bat wings’,” says Dr. Polder. “Since we offer dual sculpting, we can treat both arms at the same time, and schedule patients for one session that only lasts 35 minutes.”
CoolSculpting is a safe and effective treatment for non-invasive fat reduction. The technology is FDA-cleared for the treatment of fat bulges in the submental (below the chin) area, thigh, abdomen, flank, bra and back fat area, underneath the buttocks and now, the upper arm.
Dr. Stetler explains that CoolSculpting is not a weight-loss treatment. “Each contouring treatment reduces about 20 to 25% of fat cells in the targeted area, and most people require two sessions to achieve their desired results,” says Dr. Stetler. “CoolSculpting is most effective for stubborn pockets of fat that just won’t go away with routine exercise and maintaining a healthy diet.”
Only a select group of dermatologists currently have access to the CoolAdvantage™ Petite Applicator, with a more expanded launch to follow in the coming weeks. CoolSculpting® is developed and marketed by ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ).
About the Dallas Center for Dermatology and Aesthetics
The Dallas Center for Dermatology and Aesthetics, founded in 1991, is located in the Park Cities area of the metropolitan community. Dr. Lori Stetler and Dr. Kristel Polder are board-certified dermatologists, clinical professors, and skin care experts specializing in general medical and cosmetic dermatology, laser procedures, facial rejuvenation, injectables, and non-surgical body contouring.
For more information, please contact:
Suzie Robinson, APR
Atria Public Relations
[email protected] | 214-577-9329
1.) FDA - https://www.accessdata.fda.gov/cdrh_docs/pdf16/K162050.pdf
2.) .CoolSculpting® Announces Only FDA-Cleared Non-Invasive Treatment for Upper Arm Fat - https://globenewswire.com/news-release/2017/01/26/911210/0/en/CoolSculpting-Announces-Only-FDA-Cleared-Non-Invasive-Treatment-for-Upper-Arm-Fat.html
Suzie Robinson The Dallas Center for Dermatology and Aesthetics, 214-5779329 [email protected]


Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 



